psychosis Archive — Page 1 of 2

(iStock)
July 3, 2026

Vanderbilt Center for Cognitive Medicine seeks participants for trial evaluating Alzheimer’s disease-related psychosis treatment

The ADEPT-4 study evaluates KarXT, an oral medication that may reduce hallucinations and delusions.

May 12, 2026

Cannabis and tobacco co-use increases psychosis chances in high-risk cohorts: Study

The results highlight concern about co-use, a growing trend that has been understudied until now. Researchers defined co-use in the study as “using substances at the same time, on the same occasion, or within a defined time frame where their effects may overlap.”  

October 22, 2025

Behind the curtain: Secrets of the volatile, delusional brain 

The VUMC approach, based on the “Feeling Safe Program” developed by British psychologist Daniel Freeman, targets specific factors that contribute to persecutory delusions, including worry, safety behaviors, avoidance and hallucinations (such as hearing voices).

June 2, 2025

Landmark bequest from Charlotte and Donald Test Jr. to advance psychiatry research

Named for Donald Test’s late sons, and Charlotte’s stepsons, the Henry and William Test Endowment Fund will bolster the Department of Psychiatry and Behavioral Sciences’ expansive research portfolio, promising a secure funding source for pathbreaking discoveries in areas such as schizophrenia, coordinated care models, brain imaging and neuromodulation.

January 27, 2022

White matter and psychosis

The microstructure of white matter in the brain could be an important risk marker for psychosis, Vanderbilt researchers have discovered.

September 20, 2021

Brain circuits in schizophrenia

Vanderbilt psychiatrists are probing brain circuit hyperactivity implicated in schizophrenia, with the idea that normalizing the hyperactivity may improve cognitive processes.